Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: KPL and BSE: 539997 (ISIN INE552U01010).
It has a market capitalisation of ₹3,493 crore, a last close of ₹3,366 on 2026-10-19.
Valuation: a price-to-earnings ratio of 51.86x, a price-to-book ratio of 10.53x, a dividend yield of 0.0%.
Profitability: return on equity of 22.6%, return on capital employed of 31.2%, an operating margin of 23.5%.
Growth: sales growth of 26.1% a year over three years, net profit growth of 51.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.39x.
| Metric | Value |
|---|---|
| Market capitalisation | 3,493 |
| Last close | ₹3,366 |
| P/E (TTM) | 51.86x |
| P/B | 10.53x |
| Dividend yield | 0.0% |
| ROE (FY) | 22.6% |
| ROCE (FY) | 31.2% |
| Operating margin (TTM) | 23.5% |
| Sales growth, 3-year CAGR | 26.1% |
| Profit growth, 3-year CAGR | 51.5% |
| Debt / equity | 0.39x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means